Discovery - University of Dundee - Online Publications

Library & Learning Centre

AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase

AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase

Research output: Contribution to journalArticle

View graph of relations


  • Laurent Bultot
  • Bruno Guigas
  • Alexander Von Wilamowitz-Moellendorff
  • Liliane Maisin
  • Didier Vertommen
  • Nusrat Hussain
  • Monique Beullens
  • Joan J. Guinovart
  • Marc Foretz
  • Benoit Viollet
  • Kei Sakamoto
  • Louis Hue
  • Mark H. Rider

Research units


Original languageEnglish
Pages (from-to)193-203
Number of pages11
JournalBiochemical Journal
StatePublished - 1 Apr 2012


Recombinant muscle GYS1 (glycogen synthase 1) and recombinant liver GYS2 were phosphorylated by recombinant AMPK (AMP-activated protein kinase) in a time-dependent manner and to a similar stoichiometry. The phosphorylation site in GYS2 was identified as Ser(7), which lies in a favourable consensus for phosphorylation by AMPK. Phosphorylation of GYS1 or GYS2 by AMPK led to enzyme inactivation by decreasing the affinity for both UDP-Glc (UDP-glucose) [assayed in the absence of Glc-6-P (glucose-6-phosphate)] and Glc-6-P (assayed at low UDP-Glc concentrations). Incubation of freshly isolated rat hepatocytes with the pharmacological AMPK activators AICA riboside (5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside) or A769662 led to persistent GYS inactivation and Ser(7) phosphorylation, whereas inactivation by glucagon treatment was transient. In hepatocytes from mice harbouring a liver-specific deletion of the AMPK catalytic alpha 1/alpha 2 subunits, GYS2 inactivation by AICA riboside and A769662 was blunted, whereas inactivation by glucagon was unaffected. The results suggest that GYS inactivation by AMPK activators in hepatocytes is due to GYS2 Ser(7) phosphorylation.



Library & Learning Centre

Contact | Accessibility | Policy